Evaluation of Clinical Features of Breast Cancer in Elderly Women

This is a descriptive study that was conducted in ۲۰۲۰ by reviewing the clinical records of all women with breast cancer over the age of ۷۰ over a ten-year period ending in ۲۰۲۰ with a clinical record of ۱۸۳ patients. Demographic information, type of tumor pathology, clinical stage of the tumor, status of hormone receptors and tumor HER۲ protein, type of surgery, type of adjuvant treatment were extracted from the files and used. In ۸۸ non-metastatic patients, there were ۹۰ lymph nodes positive, of which ۳۳ (۳۷.۵%) had no estrogen receptor and ۵۵ (۶۲.۵%) had estrogen receptor. The most systemic treatment in patients with estrogen receptor-free tumor was chemotherapy (۸۱.۸%) and in patients with estrogen receptor tumor, chemotherapy plus hormone therapy (۵۸.۲%). there were ۴۰ non-metastatic lymph node-negative patients, of which ۹ (۲۲.۵%) had no estrogen receptor and ۳۱ (۷۷.۵%) had estrogen receptor. The most systemic treatment received in patients without estrogen receptor was only chemotherapy (۷۷.۸%) and in patients with estrogen receptor tumor was only hormone therapy (۵۴%). It seems that the most common stage of the disease in elderly women and over ۷۰ years is type IIB, which is also more common in these elderly women with breast cancer; Therefore, it is necessary to pay attention to these points in treatment planning

Keywords:

Breast cancer , surgery , Elderly , patients